Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Cerebral structural and functional changes in type 1 diabetes.

Stiles MC, Seaquist ER.

Minerva Med. 2010 Apr;101(2):105-14. Review.

PMID:
20467409
2.

Therapy insight: the impact of type 1 diabetes on brain development and function.

Northam EA, Rankins D, Cameron FJ.

Nat Clin Pract Neurol. 2006 Feb;2(2):78-86. Review.

PMID:
16932529
3.

Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes.

Perantie DC, Wu J, Koller JM, Lim A, Warren SL, Black KJ, Sadler M, White NH, Hershey T.

Diabetes Care. 2007 Sep;30(9):2331-7.

PMID:
17575089
4.

Cognition and brain imaging in type 1 diabetes.

Musen G.

Curr Diab Rep. 2008 Apr;8(2):132-7. Review.

PMID:
18445356
5.

Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders?

McIntyre RS, Kenna HA, Nguyen HT, Law CW, Sultan F, Woldeyohannes HO, Adams AK, Cheng JS, Lourenco M, Kennedy SH, Rasgon NL.

Adv Ther. 2010 Feb;27(2):63-80. doi: 10.1007/s12325-010-0011-z. Review.

PMID:
20390390
6.

Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.

Wessels AM, Scheltens P, Barkhof F, Heine RJ.

Eur J Pharmacol. 2008 May 6;585(1):88-96. doi: 10.1016/j.ejphar.2007.11.080. Review.

PMID:
18396273
7.

Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?

Biessels GJ, Reijmer YD.

Diabetes. 2014 Jul;63(7):2244-52. doi: 10.2337/db14-0348. Review.

8.
9.

Current status of clinical and experimental researches on cognitive impairment in diabetes.

Liang XC, Guo SS, Hagino N.

Chin J Integr Med. 2006 Mar;12(1):68-74. Review.

PMID:
16571291
10.

Structural brain imaging in diabetes: a methodological perspective.

Jongen C, Biessels GJ.

Eur J Pharmacol. 2008 May 6;585(1):208-18. doi: 10.1016/j.ejphar.2007.11.085. Review.

PMID:
18407264
11.

Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes.

Brands AM, Kessels RP, Hoogma RP, Henselmans JM, van der Beek Boter JW, Kappelle LJ, de Haan EH, Biessels GJ.

Diabetes. 2006 Jun;55(6):1800-6.

12.

Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study.

Wessels AM, Rombouts SA, Simsek S, Kuijer JP, Kostense PJ, Barkhof F, Scheltens P, Snoek FJ, Heine RJ.

Diabetes. 2006 Feb;55(2):334-40.

13.

The Impact of Diabetes on Cerebral Structure and Function.

Seaquist ER.

Psychosom Med. 2015 Jul-Aug;77(6):616-21. doi: 10.1097/PSY.0000000000000207. Review.

PMID:
26163815
14.

The Scylla and Charybdis of glucose control in childhood type 1 diabetes?

McNeilly AD, McCrimmon RJ.

Pediatr Diabetes. 2015 Jun;16(4):235-41. doi: 10.1111/pedi.12270. Review.

PMID:
25727089
15.

Neuroimaging in patients with abnormal blood glucose levels.

Bathla G, Policeni B, Agarwal A.

AJNR Am J Neuroradiol. 2014 May;35(5):833-40. doi: 10.3174/ajnr.A3486. Review.

16.

Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia.

Ferguson SC, Blane A, Perros P, McCrimmon RJ, Best JJ, Wardlaw J, Deary IJ, Frier BM.

Diabetes. 2003 Jan;52(1):149-56.

17.

The effects of glucose fluctuation on cognitive function and QOL: the functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes.

Cox D, Gonder-Frederick L, McCall A, Kovatchev B, Clarke W.

Int J Clin Pract Suppl. 2002 Jul;(129):20-6. Review.

PMID:
12166601
18.

[Diabetic encephalopathy: an underexposed complication of diabetes mellitus].

Brands AM, Henselmans JM, de Haan EH, Biessels GJ.

Ned Tijdschr Geneeskd. 2003 Jan 4;147(1):11-4. Review. Dutch.

PMID:
12564291
19.

Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes.

Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ, Biessels GJ; Utrecht Diabetic Encephalopathy Study Group..

Diabetes. 2006 Apr;55(4):1106-13.

20.

Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.

van den Berg E, Kessels RP, Kappelle LJ, de Haan EH, Biessels GJ; Utrecht Diabetic Encephalopathy Study Group..

Drugs Today (Barc). 2006 Nov;42(11):741-54. Review.

PMID:
17171193
Items per page

Supplemental Content

Support Center